(Q30437215)

19 August 2017

Impact of asthma controller medications on clinical, economic, and patient-reported outcomes (English)

1 reference

19 August 2017

1 reference

1 reference

Hiangkiat Tan

1

1 reference

19 August 2017

Chaitanya Sarawate

2

1 reference

19 August 2017

Joseph Singer

3

1 reference

19 August 2017

Kurt Elward

4

1 reference

19 August 2017

Rubin I Cohen

5

1 reference

19 August 2017

Brian A Smart

6

1 reference

19 August 2017

Michael F Busk

7

1 reference

19 August 2017

James Lustig

8

1 reference

19 August 2017

Jeana D O'Brien

9

1 reference

19 August 2017

Michael Schatz

10

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

19 August 2017

1 reference

19 August 2017

84

1 reference

19 August 2017

8

1 reference

19 August 2017

675-684

1 reference

Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

20 June 2018

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Adherence to Prescribed Treatment for Asthma: Evidence from Pharmacy Benefits Data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Treatment effectiveness of inhaled corticosteroids and leukotriene modifiers for patients with asthma: an analysis from managed care data.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Asthma costs and utilization in a managed care organization

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Asthma population management: development and validation of a practical 3-level risk stratification scheme.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Surveillance for asthma--United States, 1980-1999.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2719520

The validity and reproducibility of a work productivity and activity impairment instrument

26 November 2018

1 reference

12 December 2020

Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial

1 reference

12 December 2020

Development and validation of the Mini Asthma Quality of Life Questionnaire

1 reference

12 December 2020

Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma

1 reference

12 December 2020

Association of asthma control with health care utilization and quality of life

1 reference

12 December 2020

Identifiers

DOI

10.4065/84.8.675

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19648384

1 reference